Cell Signaling Technology

Torin 1

#14379 · $210

100
Citing papers
8.6k
Combined citations
Supplier page Find this product

Research areas

Ubiquitin and proteasome pathways12Endoplasmic Reticulum Stress and Disease12Cell death mechanisms and regulation12Autophagy in Disease and Therapy10Adipose Tissue and Metabolism9NF-κB Signaling Pathways9Glioma Diagnosis and Treatment8Multiple Myeloma Research and Treatments7

Papers citing this product

1
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Blood·2006·1.1k cit.·DOI
2
Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells
Blood·2006·421 cit.·DOI
3
SIRT4 Regulates Fatty Acid Oxidation and Mitochondrial Gene Expression in Liver and Muscle Cells
Journal of Biological Chemistry·2010·321 cit.·DOI
4
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma
Blood·2009·310 cit.·DOI
5
Striatal Adenosine A2A and Cannabinoid CB1 Receptors Form Functional Heteromeric Complexes that Mediate the Motor Effects of Cannabinoids
Neuropsychopharmacology·2007·249 cit.·DOI
6
Rescue of Dystrophic Skeletal Muscle by PGC-1α Involves a Fast to Slow Fiber Type Shift in the mdx Mouse
PLoS ONE·2012·197 cit.·DOI
7
The role of Rat1 in coupling mRNA 3′-end processing to transcription termination: implications for a unified allosteric–torpedo model
Genes & Development·2006·191 cit.·DOI
8
The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival
The Journal of Immunology·2008·191 cit.·DOI
9
Sustained elevation of Snail promotes glial-mesenchymal transition after irradiation in malignant glioma
Neuro-Oncology·2013·171 cit.·DOI
10
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02
Neuro-Oncology·2014·166 cit.·DOI
Torin 1 — Evidence — PubIndex